How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Detection of Rat Lungworm (Angiostrongylus cantonensis) in Rats and Gastropods, Italy – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Novel Henipavirus, Salt Gully Virus, Isolated from Pteropid Bats, Australia – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Genetic Characterization of Orientia tsutsugamushi, Bhutan, 2015 – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Insights into Infant Strongyloidiasis, Papua New Guinea – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Apicoplast [ā′-pik-ō-plast] – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Linezolid and Meropenem for Nocardia otitidiscaviarum Actinomycetoma, India – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Theileria luwenshuni and Novel Babesia spp. Infections in Humans, Yunnan Province, China – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Differences in Lyme Disease Diagnosis among Medicaid and Medicare Beneficiaries, United States, 2016–2021 – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us